Pub Date : 2026-01-15Epub Date: 2025-10-07DOI: 10.1016/j.xhgg.2025.100528
Frederike L Harms, Fanny Kortüm, Malik Alawi, Martin Staudt, Kerstin Kutsche
Congenital mirror movements (CMMs) are involuntary movements of one side of the body that mirror intentional movements of the opposite side. DCC, NTN1, RAD51, ARHGEF7, and DNAL4 have been associated with CMMs. Two-thirds of CMM-affected individuals remain without a genetic diagnosis, indicating that variants in additional genes need to be discovered. We report on a 27-year-old female with CMMs of the hands. Trio exome sequencing in the proband and healthy parents did not reveal a likely pathogenic variant in one of the CMM-associated genes but rather a de novo heterozygous frameshift variant c.523dup (p.Ser175Lysfs∗8) in the candidate RBM15. The variant results in only partial nonsense-mediated mRNA decay of RBM15 transcripts in the proband's lymphoblastoid cells. RBM15 encodes an RNA-binding protein involved in alternative splicing as well as other processes. Dcc alternative splicing generates Dcclong and Dccshort isoforms, which are important for commissural axon midline crossing. We tested whether Rbm15 regulates Dcc alternative splicing by using an in vitro minigene assay. Ectopic expression of Rbm15, similar to the splicing factors Nova1 and Nova2, promotes the production of Dcclong transcripts. The possible link between Rbm15 and Dcc supports a role for Rbm15 in CMMs.
{"title":"A de novo frameshift variant in the candidate RBM15 in a proband with congenital mirror movements.","authors":"Frederike L Harms, Fanny Kortüm, Malik Alawi, Martin Staudt, Kerstin Kutsche","doi":"10.1016/j.xhgg.2025.100528","DOIUrl":"10.1016/j.xhgg.2025.100528","url":null,"abstract":"<p><p>Congenital mirror movements (CMMs) are involuntary movements of one side of the body that mirror intentional movements of the opposite side. DCC, NTN1, RAD51, ARHGEF7, and DNAL4 have been associated with CMMs. Two-thirds of CMM-affected individuals remain without a genetic diagnosis, indicating that variants in additional genes need to be discovered. We report on a 27-year-old female with CMMs of the hands. Trio exome sequencing in the proband and healthy parents did not reveal a likely pathogenic variant in one of the CMM-associated genes but rather a de novo heterozygous frameshift variant c.523dup (p.Ser175Lysfs∗8) in the candidate RBM15. The variant results in only partial nonsense-mediated mRNA decay of RBM15 transcripts in the proband's lymphoblastoid cells. RBM15 encodes an RNA-binding protein involved in alternative splicing as well as other processes. Dcc alternative splicing generates Dcc<sub>long</sub> and Dcc<sub>short</sub> isoforms, which are important for commissural axon midline crossing. We tested whether Rbm15 regulates Dcc alternative splicing by using an in vitro minigene assay. Ectopic expression of Rbm15, similar to the splicing factors Nova1 and Nova2, promotes the production of Dcc<sub>long</sub> transcripts. The possible link between Rbm15 and Dcc supports a role for Rbm15 in CMMs.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100528"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12554026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-10-31DOI: 10.1016/j.xhgg.2025.100541
Kristy L Jay, Nikhita Gogate, Paige I Hall, Kimberly M Ezell, Jonathan C Andrews, Sharayu V Jangam, Hongling Pan, Kelvin Pham, Ryan German, Vanessa Gomez, Emily Jellinek-Russo, Eric A Storch, Shinya Yamamoto, Oguz Kanca, Hugo J Bellen, Herman A Dierick, Joy D Cogan, John A Phillips, Rizwan Hamid, Thomas Cassini, Lynette Rives, Sumit Pruthi, Hua-Chang Chen, Jennifer E Posey, Michael F Wangler
Variants in SLC6A1 result in a rare neurodevelopmental disorder characterized by a variable clinical presentation of symptoms including developmental delay, epilepsy, motor dysfunction, and autism spectrum disorder. SLC6A1 haploinsufficiency has been confirmed as the predominant pathway of SLC6A1-related neurodevelopmental disorder (SLC6A1-NDD); however, the molecular mechanism underlying the variable clinical presentation remains unclear. Here, through work of the Undiagnosed Diseases Network, we identify an individual with an inherited p.A334S variant of uncertain significance. To resolve this variant and better understand the variable expressivity associated with SLC6A1, we assess the phenotypes of the proband in comparison with a cohort of 13 individuals diagnosed with SLC6A1-NDD. We then create an allelic series in Drosophila melanogaster to functionally characterize these variants. Informatic clustering based on these clinical findings points to significant clinical overlap between the unsolved individual and confirmed SLC6A1-NDD. We confirm phenotypes in flies expressing SLC6A1 variants consistent with a partial loss-of-function mechanism. We conclude that the p.A334S variant is a hypomorphic allele and begin to elucidate the underlying variability in SLC6A1-NDD. These insights will inform clinical diagnosis, prognosis, intervention, and inform therapeutic design for those living with SLC6A1-NDD.
{"title":"Resolving SLC6A1 variable expressivity with deep clinical phenotyping and Drosophila models.","authors":"Kristy L Jay, Nikhita Gogate, Paige I Hall, Kimberly M Ezell, Jonathan C Andrews, Sharayu V Jangam, Hongling Pan, Kelvin Pham, Ryan German, Vanessa Gomez, Emily Jellinek-Russo, Eric A Storch, Shinya Yamamoto, Oguz Kanca, Hugo J Bellen, Herman A Dierick, Joy D Cogan, John A Phillips, Rizwan Hamid, Thomas Cassini, Lynette Rives, Sumit Pruthi, Hua-Chang Chen, Jennifer E Posey, Michael F Wangler","doi":"10.1016/j.xhgg.2025.100541","DOIUrl":"10.1016/j.xhgg.2025.100541","url":null,"abstract":"<p><p>Variants in SLC6A1 result in a rare neurodevelopmental disorder characterized by a variable clinical presentation of symptoms including developmental delay, epilepsy, motor dysfunction, and autism spectrum disorder. SLC6A1 haploinsufficiency has been confirmed as the predominant pathway of SLC6A1-related neurodevelopmental disorder (SLC6A1-NDD); however, the molecular mechanism underlying the variable clinical presentation remains unclear. Here, through work of the Undiagnosed Diseases Network, we identify an individual with an inherited p.A334S variant of uncertain significance. To resolve this variant and better understand the variable expressivity associated with SLC6A1, we assess the phenotypes of the proband in comparison with a cohort of 13 individuals diagnosed with SLC6A1-NDD. We then create an allelic series in Drosophila melanogaster to functionally characterize these variants. Informatic clustering based on these clinical findings points to significant clinical overlap between the unsolved individual and confirmed SLC6A1-NDD. We confirm phenotypes in flies expressing SLC6A1 variants consistent with a partial loss-of-function mechanism. We conclude that the p.A334S variant is a hypomorphic allele and begin to elucidate the underlying variability in SLC6A1-NDD. These insights will inform clinical diagnosis, prognosis, intervention, and inform therapeutic design for those living with SLC6A1-NDD.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100541"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12681531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145422985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-09-27DOI: 10.1016/j.xhgg.2025.100524
Carissa A Sherman, Nanibaa' A Garrison, Katrina G Claw
The Navajo Nation is reevaluating a moratorium on genetic research that was authorized in 2002. While the moratorium was instituted due to cultural concerns and the lack of a Navajo genetic research policy, there remains limited empirical work assessing the perspectives of Diné (Navajo) people and other interest holders regarding genetic research. To address this gap, this study examines the perspectives of research project leaders with protocols approved by the Navajo Nation Human Research Review Board (NNHRRB) as this group is aware of research expectations and cultural considerations. An online survey was designed to gauge researchers' interest in adding a genetic component to their research if the moratorium were lifted, while also examining potential benefits, risks, and ethical considerations. Survey participants (n = 36) included 27% Diné researchers and 73% non-Diné researchers, and 50% of researchers (n = 18) had collected human biospecimens in their research (e.g., blood, tissue). Our results indicate that, if the moratorium on genetic research ended, 42% of researchers (n = 15) would be unsure about adding a genetic component to their projects, while 31% (n = 11) of researchers were interested. Participants were asked to rank ethical considerations related to five broad topics: community engagement; dissemination of results and data; privacy and rights; health, safety, and equity; and discrimination and mistrust. Participants ranked "ensure that no research participants are harmed" and "give presentations to the community" as very important, whereas "sharing data with other researchers" was of low importance. We provide valuable perspectives to guide potential genetic policy development for the Navajo Nation.
{"title":"Researcher attitudes toward hypothetical genetic research with Navajo people: Results from an online survey.","authors":"Carissa A Sherman, Nanibaa' A Garrison, Katrina G Claw","doi":"10.1016/j.xhgg.2025.100524","DOIUrl":"10.1016/j.xhgg.2025.100524","url":null,"abstract":"<p><p>The Navajo Nation is reevaluating a moratorium on genetic research that was authorized in 2002. While the moratorium was instituted due to cultural concerns and the lack of a Navajo genetic research policy, there remains limited empirical work assessing the perspectives of Diné (Navajo) people and other interest holders regarding genetic research. To address this gap, this study examines the perspectives of research project leaders with protocols approved by the Navajo Nation Human Research Review Board (NNHRRB) as this group is aware of research expectations and cultural considerations. An online survey was designed to gauge researchers' interest in adding a genetic component to their research if the moratorium were lifted, while also examining potential benefits, risks, and ethical considerations. Survey participants (n = 36) included 27% Diné researchers and 73% non-Diné researchers, and 50% of researchers (n = 18) had collected human biospecimens in their research (e.g., blood, tissue). Our results indicate that, if the moratorium on genetic research ended, 42% of researchers (n = 15) would be unsure about adding a genetic component to their projects, while 31% (n = 11) of researchers were interested. Participants were asked to rank ethical considerations related to five broad topics: community engagement; dissemination of results and data; privacy and rights; health, safety, and equity; and discrimination and mistrust. Participants ranked \"ensure that no research participants are harmed\" and \"give presentations to the community\" as very important, whereas \"sharing data with other researchers\" was of low importance. We provide valuable perspectives to guide potential genetic policy development for the Navajo Nation.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100524"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12554029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-10-08DOI: 10.1016/j.xhgg.2025.100529
Daniel E Cruz, Shuliang Deng, Usman A Tahir, Zsu-Zsu Chen, Mark D Benson, Bjoernar Tuftin, Jiawen Chen, Laurie Farrell, Dongxiao Shen, Mariah Meyer, Ethan Lange, Yan Gao, Michael E Hall, Russell P Tracy, Stephen S Rich, Kent Taylor, Ani Manichaikul, Jerome I Rotter, Tamar Sofer, James G Wilson, Robert E Gerszten, Laura M Raffield
Protein profiling and genetic findings can be integrated to define the genetic architecture of the circulating proteome in chronic diseases. Most self-identified African American (AA) individuals have both African and European genetic ancestry. Admixture mapping can detect genomic association regions in which causal variants exist with substantial differences in allele frequency or effect sizes between genetic ancestries. We performed admixture mapping of the circulating proteome in 1,989 participants from the Jackson Heart Study (JHS), investigating the relation of local African ancestry within genomic regions with levels of circulating proteins. We conditioned protein-local ancestry association models on variants previously found to be associated with those proteins in genome-wide association studies (GWASs). We replicated findings in 196 AA participants from the Multi-Ethnic Study of Atherosclerosis (MESA). 62 proteins were associated with local African ancestry. 21 of 62 remained statistically significant after conditioning on protein-associated variants observed in previous GWASs. 48 of 54 available protein-local ancestry associations were replicated in the MESA. Proteins associated with local African ancestry included chemokines, factors associated with vascular biology and inflammation, and other biologically interesting proteins. Admixture associations unexplained by previously reported protein-associated variants in conditional analysis suggest the existence of causal variants missed by standard GWAS techniques.
{"title":"Admixture-mapping analysis reveals genetic determinants of the human plasma proteome.","authors":"Daniel E Cruz, Shuliang Deng, Usman A Tahir, Zsu-Zsu Chen, Mark D Benson, Bjoernar Tuftin, Jiawen Chen, Laurie Farrell, Dongxiao Shen, Mariah Meyer, Ethan Lange, Yan Gao, Michael E Hall, Russell P Tracy, Stephen S Rich, Kent Taylor, Ani Manichaikul, Jerome I Rotter, Tamar Sofer, James G Wilson, Robert E Gerszten, Laura M Raffield","doi":"10.1016/j.xhgg.2025.100529","DOIUrl":"10.1016/j.xhgg.2025.100529","url":null,"abstract":"<p><p>Protein profiling and genetic findings can be integrated to define the genetic architecture of the circulating proteome in chronic diseases. Most self-identified African American (AA) individuals have both African and European genetic ancestry. Admixture mapping can detect genomic association regions in which causal variants exist with substantial differences in allele frequency or effect sizes between genetic ancestries. We performed admixture mapping of the circulating proteome in 1,989 participants from the Jackson Heart Study (JHS), investigating the relation of local African ancestry within genomic regions with levels of circulating proteins. We conditioned protein-local ancestry association models on variants previously found to be associated with those proteins in genome-wide association studies (GWASs). We replicated findings in 196 AA participants from the Multi-Ethnic Study of Atherosclerosis (MESA). 62 proteins were associated with local African ancestry. 21 of 62 remained statistically significant after conditioning on protein-associated variants observed in previous GWASs. 48 of 54 available protein-local ancestry associations were replicated in the MESA. Proteins associated with local African ancestry included chemokines, factors associated with vascular biology and inflammation, and other biologically interesting proteins. Admixture associations unexplained by previously reported protein-associated variants in conditional analysis suggest the existence of causal variants missed by standard GWAS techniques.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100529"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12657719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145259564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-09-27DOI: 10.1016/j.xhgg.2025.100523
Federico Ferraro, Nikolas Kühn, Dmitrijs Rots, Herma C van der Linde, Banin Mohseni, Leontine van Unen, Mark Drost, Mark Nellist, Marieke Koekkoek, Rachel Schot, Henriette W de Gier, Mieke Pleumeekers, Tahsin Stefan Barakat, Tjitske Kleefstra, Marjolein Weerts, Marieke F van Dooren, Tjakko J van Ham
Treacher Collins syndrome (TCS) is a craniofacial genetic disorder caused by loss-of-function variants in TCOF1, POLR1B, POLR1C, or POLR1D. Here, we describe two previously undiagnosed paternal half-siblings affected with clinical TCS, and their apparently unaffected father. Diagnostic short-read RNA sequencing) identified aberrant expression of TCOF1 and optical genome mapping detected a large genomic insertion therein. Long-read genome sequencing (lrGS) resolved a deep intronic 3.5 kb SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 17 of TCOF1. Long-read RNA sequencing (lrRNA-seq) demonstrated that the insertion was partially exonized inducing isoform switch to the shorter non-canonical TCOF1 isoform c. SVA insertion was confirmed in both half-siblings, and we detected mosaicism in the father. This work demonstrates the potential of lrRNA-seq and lrGS, to identify pathogenic variants in unexplained genetic disorders.
Treacher Collins综合征(TCS)是一种颅面遗传疾病,由TCOF1、POLR1B、POLR1C或POLR1D的功能变异丧失引起。在这里,我们描述了两个以前未确诊的父亲同父异母兄弟姐妹感染临床TCS,和他们的父亲显然未受影响。诊断性短读rna测序(srRNA-Seq)鉴定了TCOF1的异常表达,光学基因组定位检测到其中有一个大的基因组插入。长读基因组测序(lrGS)在TCOF1的17号内含子中发现了一个深3.5 kb的sin - vntr - alu (SVA)反转录转座子插入。长读RNA-seq (lrRNA-Seq)显示,插入部分外显子化,诱导了短的非规范TCOF1异构体c的转换。sva插入在两个同父异母兄弟姐妹中都得到了证实,我们在父亲身上检测到了镶嵌现象。这项工作证明了lrRNA-Seq和lrGS在鉴定不明原因遗传疾病的致病变异方面的潜力。
{"title":"Long-read DNA and RNA sequencing reveal an intronic retrotransposon insertion in TCOF1 causing Treacher Collins syndrome.","authors":"Federico Ferraro, Nikolas Kühn, Dmitrijs Rots, Herma C van der Linde, Banin Mohseni, Leontine van Unen, Mark Drost, Mark Nellist, Marieke Koekkoek, Rachel Schot, Henriette W de Gier, Mieke Pleumeekers, Tahsin Stefan Barakat, Tjitske Kleefstra, Marjolein Weerts, Marieke F van Dooren, Tjakko J van Ham","doi":"10.1016/j.xhgg.2025.100523","DOIUrl":"10.1016/j.xhgg.2025.100523","url":null,"abstract":"<p><p>Treacher Collins syndrome (TCS) is a craniofacial genetic disorder caused by loss-of-function variants in TCOF1, POLR1B, POLR1C, or POLR1D. Here, we describe two previously undiagnosed paternal half-siblings affected with clinical TCS, and their apparently unaffected father. Diagnostic short-read RNA sequencing) identified aberrant expression of TCOF1 and optical genome mapping detected a large genomic insertion therein. Long-read genome sequencing (lrGS) resolved a deep intronic 3.5 kb SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 17 of TCOF1. Long-read RNA sequencing (lrRNA-seq) demonstrated that the insertion was partially exonized inducing isoform switch to the shorter non-canonical TCOF1 isoform c. SVA insertion was confirmed in both half-siblings, and we detected mosaicism in the father. This work demonstrates the potential of lrRNA-seq and lrGS, to identify pathogenic variants in unexplained genetic disorders.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100523"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12816837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-12-18DOI: 10.1016/j.xhgg.2025.100559
Sean T Congdon, John Bennett, Rhoddean Opinya, Amara R Agosto, Olivia Dossias, Christopher Kokko, Aime A Levesque, Andrew O Koob, Adam C Silver, Cindy A Thomas-Charles
Single-nucleotide variants (SNVs) and small insertions or deletions (indels) underlie most rare monogenic disorders, yet therapeutic strategies to precisely correct these mutations remain limited. Prime editing enables the repair of such pathogenic variants without introducing double-stranded breaks. Here, we applied CRISPR prime editing to model and correct a de novo GDF11 nonsense mutation (Tyr336∗) identified in a participant from the Undiagnosed Diseases Network with growth delay and multisystem abnormalities. Using HEK293T cells, we generated heterozygous (HET) GDF11 Tyr336∗ clones, which exhibited reduced GDF11 protein levels due to post-translational degradation likely mediated by endoplasmic reticulum- and Golgi-associated quality control pathways. These cells displayed marked Golgi abnormalities, including an increased number of compact, irregularly shaped Golgi structures, findings consistent with Golgi fragmentation and stress. Transcriptomic profiling of HET cells revealed a broad dysregulation of gene networks, including downregulation of metabolic and Golgi-linked biosynthetic genes, and upregulation of cell-adhesion and extracellular matrix genes. These transcriptional shifts paralleled the participant's developmental, neural, and cardiovascular phenotypes. To correct the mutation, we tested multiple bespoke prime editing strategies and identified PE7, in combination with a prime editing guide RNA designed by Pridict, as the most effective ribonucleoprotein complex for rescue. Editing efficiency was further enhanced by introducing an additional silent protospacer-adjacent motif-disrupting mutation, likely preventing both Cas9 re-binding and mismatch repair. Together, these findings support a haploinsufficiency mechanism for the GDF11 Tyr336∗ allele and establish a generalizable framework for disease modeling and allele-specific correction of pathogenic variants in human cells.
{"title":"Investigating and correcting a rare pathogenic mutation in GDF11.","authors":"Sean T Congdon, John Bennett, Rhoddean Opinya, Amara R Agosto, Olivia Dossias, Christopher Kokko, Aime A Levesque, Andrew O Koob, Adam C Silver, Cindy A Thomas-Charles","doi":"10.1016/j.xhgg.2025.100559","DOIUrl":"10.1016/j.xhgg.2025.100559","url":null,"abstract":"<p><p>Single-nucleotide variants (SNVs) and small insertions or deletions (indels) underlie most rare monogenic disorders, yet therapeutic strategies to precisely correct these mutations remain limited. Prime editing enables the repair of such pathogenic variants without introducing double-stranded breaks. Here, we applied CRISPR prime editing to model and correct a de novo GDF11 nonsense mutation (Tyr336∗) identified in a participant from the Undiagnosed Diseases Network with growth delay and multisystem abnormalities. Using HEK293T cells, we generated heterozygous (HET) GDF11 Tyr336∗ clones, which exhibited reduced GDF11 protein levels due to post-translational degradation likely mediated by endoplasmic reticulum- and Golgi-associated quality control pathways. These cells displayed marked Golgi abnormalities, including an increased number of compact, irregularly shaped Golgi structures, findings consistent with Golgi fragmentation and stress. Transcriptomic profiling of HET cells revealed a broad dysregulation of gene networks, including downregulation of metabolic and Golgi-linked biosynthetic genes, and upregulation of cell-adhesion and extracellular matrix genes. These transcriptional shifts paralleled the participant's developmental, neural, and cardiovascular phenotypes. To correct the mutation, we tested multiple bespoke prime editing strategies and identified PE7, in combination with a prime editing guide RNA designed by Pridict, as the most effective ribonucleoprotein complex for rescue. Editing efficiency was further enhanced by introducing an additional silent protospacer-adjacent motif-disrupting mutation, likely preventing both Cas9 re-binding and mismatch repair. Together, these findings support a haploinsufficiency mechanism for the GDF11 Tyr336∗ allele and establish a generalizable framework for disease modeling and allele-specific correction of pathogenic variants in human cells.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100559"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12825063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Morphine is a potent analgesic and exhibits significant efficacy in alleviating severe pain. However, prolonged use can lead to drug dependency. Moreover, there are individual variations in response to and tolerance of morphine, indicating potential genetic regulation. Nevertheless, the mechanisms underlying these phenomena remain unclear. Therefore, we aimed to systematically dissect the genetic regulatory network for morphine response. We used quantitative trait locus mapping to identify genetic regions associated with morphine-related traits. Candidate genes for each locus were further filtered based on multiple criteria, including gene-trait association, cis-regulation, genetic variation, and potential function. The results showed that morphine response-related behavioral traits were significantly influenced by genetic background. Using the GEMMA and HK algorithms, we identified 18 genomic loci associated with dozens of morphine response-related traits. This includes loci previously studied on chromosome 10, together with a locus on chromosome 5 (0-20 Mb) identified in our analysis which showed the most association outside chromosome 10. Additionally, we identified six candidate functional genes (Cacna2d1, Myo7a, Elovl4, Oprm1, Cdk12, and Ccdc88c) that passed the filtering criteria. Oprm1 encodes the μ-opioid receptor, while Cacna2d1, Cdk12, and Elovl4 are closely associated with neurons. Myo7a and Ccdc88c may mediate anxiety and cognitive dysfunction caused by morphine dependence. Furthermore, Oprm1, Cacna2d1, and Ccdc88c are associated with opioid use disorders, nerve measurements, and brain volume in humans. In summary, our study describes the genetic regulation landscape of morphine response in BXD mice and identifies six candidate genes, providing valuable opportunities for further exploration.
{"title":"Genetic landscape of morphine response in BXD recombinant inbred mice.","authors":"Quanting Yin, Xiaoyu Yang, Siying Ju, Hongjie He, Zhe Han, Cuicui Yu, Shushan Jia, Lu Lu, Geng Tian, Jia Mi, Chunhua Yang, Fuyi Xu","doi":"10.1016/j.xhgg.2025.100535","DOIUrl":"10.1016/j.xhgg.2025.100535","url":null,"abstract":"<p><p>Morphine is a potent analgesic and exhibits significant efficacy in alleviating severe pain. However, prolonged use can lead to drug dependency. Moreover, there are individual variations in response to and tolerance of morphine, indicating potential genetic regulation. Nevertheless, the mechanisms underlying these phenomena remain unclear. Therefore, we aimed to systematically dissect the genetic regulatory network for morphine response. We used quantitative trait locus mapping to identify genetic regions associated with morphine-related traits. Candidate genes for each locus were further filtered based on multiple criteria, including gene-trait association, cis-regulation, genetic variation, and potential function. The results showed that morphine response-related behavioral traits were significantly influenced by genetic background. Using the GEMMA and HK algorithms, we identified 18 genomic loci associated with dozens of morphine response-related traits. This includes loci previously studied on chromosome 10, together with a locus on chromosome 5 (0-20 Mb) identified in our analysis which showed the most association outside chromosome 10. Additionally, we identified six candidate functional genes (Cacna2d1, Myo7a, Elovl4, Oprm1, Cdk12, and Ccdc88c) that passed the filtering criteria. Oprm1 encodes the μ-opioid receptor, while Cacna2d1, Cdk12, and Elovl4 are closely associated with neurons. Myo7a and Ccdc88c may mediate anxiety and cognitive dysfunction caused by morphine dependence. Furthermore, Oprm1, Cacna2d1, and Ccdc88c are associated with opioid use disorders, nerve measurements, and brain volume in humans. In summary, our study describes the genetic regulation landscape of morphine response in BXD mice and identifies six candidate genes, providing valuable opportunities for further exploration.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":"7 1","pages":"100535"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12666343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145557827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-11-27DOI: 10.1016/j.xhgg.2025.100551
John Baierl, Jonathan P Tyrer, Ping-Hung Lai, Simon A Gayther, Yi-Wen Hsiao, Michelle Jones, Paul D P Pharoah, Pei-Chen Peng
Polygenic scores (PGSs) have shown promise in advancing precision medicine by capturing the additive effects of common genetic variants to assess inherited disease risk. However, their predictive accuracy remains limited in non-European populations. We enhanced our previously developed Bayesian polygenic model, "select and shrink with summary statistics" (S4), by introducing a multi-ancestry extension (S4-Multi) to improve prediction accuracy across African, American, East Asian, European, and South Asian ancestries. By leveraging simulated data and biobank cohorts from UK Biobank, FinnGen, Biobank Japan, the All of Us Research Program, and the Global Biobank Meta-Analysis Initiative, we benchmarked S4-Multi against leading methods for predicting type 2 diabetes, breast cancer, colorectal cancer, asthma, and stroke. In simulation tests, S4-Multi outperformed its single-ancestry version, achieving over 1.6 times greater accuracy in non-European populations, and matched or exceeded top-performing methods across all tested ancestry groups. In biobank tests, S4-Multi matched the performance of the best methods, varying by ancestry and phenotype. We find that S4-Multi achieves comparable performance using 9%-77% fewer genetic variants than competing models, highlighting potential for robust performance in clinical settings with limited available genomic data.
多基因评分(pgs)通过捕获常见基因变异的加性效应来评估遗传疾病的风险,在推进精准医学方面显示出了希望。然而,它们在非欧洲人群中的预测准确性仍然有限。我们通过引入多祖先扩展(S4- multi)来提高对非洲、美洲、东亚、欧洲和南亚祖先的预测精度,从而增强了我们之前开发的贝叶斯多基因模型——Select and Shrink with Summary Statistics (S4)。通过利用模拟数据和来自UK biobank、FinnGen、biobank Japan、All of Us Research Program和Global biobank Meta-Analysis Initiative的生物库队列,我们将S4-Multi与预测2型糖尿病、乳腺癌、结直肠癌、哮喘和中风的领先方法进行了基准比较。在模拟测试中,S4-Multi优于其单一祖先版本,在非欧洲人群中实现了超过1.6倍的准确性,并且在所有测试的祖先群体中匹配或超过了表现最好的方法。在生物库测试中,S4-Multi匹配最佳方法的性能,因血统和表型而异。我们发现S4-Multi与竞争模型相比,使用较少9%至77%的遗传变异实现了相当的性能,突出了在可用基因组数据有限的临床环境中具有强大性能的潜力。
{"title":"S4-multi: Enhancing polygenic score prediction in ancestrally diverse populations.","authors":"John Baierl, Jonathan P Tyrer, Ping-Hung Lai, Simon A Gayther, Yi-Wen Hsiao, Michelle Jones, Paul D P Pharoah, Pei-Chen Peng","doi":"10.1016/j.xhgg.2025.100551","DOIUrl":"10.1016/j.xhgg.2025.100551","url":null,"abstract":"<p><p>Polygenic scores (PGSs) have shown promise in advancing precision medicine by capturing the additive effects of common genetic variants to assess inherited disease risk. However, their predictive accuracy remains limited in non-European populations. We enhanced our previously developed Bayesian polygenic model, \"select and shrink with summary statistics\" (S4), by introducing a multi-ancestry extension (S4-Multi) to improve prediction accuracy across African, American, East Asian, European, and South Asian ancestries. By leveraging simulated data and biobank cohorts from UK Biobank, FinnGen, Biobank Japan, the All of Us Research Program, and the Global Biobank Meta-Analysis Initiative, we benchmarked S4-Multi against leading methods for predicting type 2 diabetes, breast cancer, colorectal cancer, asthma, and stroke. In simulation tests, S4-Multi outperformed its single-ancestry version, achieving over 1.6 times greater accuracy in non-European populations, and matched or exceeded top-performing methods across all tested ancestry groups. In biobank tests, S4-Multi matched the performance of the best methods, varying by ancestry and phenotype. We find that S4-Multi achieves comparable performance using 9%-77% fewer genetic variants than competing models, highlighting potential for robust performance in clinical settings with limited available genomic data.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100551"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12799782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145640741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-11-04DOI: 10.1016/j.xhgg.2025.100542
Haoling Xu, Zhen Liu, Fadi F Hamdan, Shengnan Wu, Mei He, Dan Wang, Hu Pan, Juanli Hu, Yiqiao Chen, Jacques L Michaud, Berge A Minassian, Jing Duan, Jianxiang Liao, Jinping Su, Sainan Hu, Yin Peng, Qinyong Ye, Li Chen
Microcephaly is a neurodevelopmental anomaly characterized by reduced head circumference and impaired brain growth, often accompanied by intellectual disability (ID), developmental delays, and seizures. While numerous genes have been implicated in microcephaly, the role of the SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complex, particularly its core component CUL1, remains poorly understood. In this study, we identified heterozygous de novo and inherited variants in the CUL1 gene in four unrelated families with severe microcephaly, ID, and developmental delays. To investigate the functional consequences of CUL1 loss of function, we developed a zebrafish model with knockdown of cul1a&b, which exhibited significant reductions in central nervous system size and behavioral defects, mirroring the clinical phenotypes observed in patients. These findings establish CUL1 as a novel gene associated with severe neurodevelopmental disorders (NDDs) and highlight its critical role in brain development. Our study provides genotype-phenotype correlations for CUL1 in NDDs, expanding the genetic spectrum of disorders linked to the SCF complex and underscoring its importance in neurodevelopment.
{"title":"CUL1 variants cause severe neurodevelopmental disorders: Insights from human genetics and a zebrafish model of microcephaly.","authors":"Haoling Xu, Zhen Liu, Fadi F Hamdan, Shengnan Wu, Mei He, Dan Wang, Hu Pan, Juanli Hu, Yiqiao Chen, Jacques L Michaud, Berge A Minassian, Jing Duan, Jianxiang Liao, Jinping Su, Sainan Hu, Yin Peng, Qinyong Ye, Li Chen","doi":"10.1016/j.xhgg.2025.100542","DOIUrl":"10.1016/j.xhgg.2025.100542","url":null,"abstract":"<p><p>Microcephaly is a neurodevelopmental anomaly characterized by reduced head circumference and impaired brain growth, often accompanied by intellectual disability (ID), developmental delays, and seizures. While numerous genes have been implicated in microcephaly, the role of the SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complex, particularly its core component CUL1, remains poorly understood. In this study, we identified heterozygous de novo and inherited variants in the CUL1 gene in four unrelated families with severe microcephaly, ID, and developmental delays. To investigate the functional consequences of CUL1 loss of function, we developed a zebrafish model with knockdown of cul1a&b, which exhibited significant reductions in central nervous system size and behavioral defects, mirroring the clinical phenotypes observed in patients. These findings establish CUL1 as a novel gene associated with severe neurodevelopmental disorders (NDDs) and highlight its critical role in brain development. Our study provides genotype-phenotype correlations for CUL1 in NDDs, expanding the genetic spectrum of disorders linked to the SCF complex and underscoring its importance in neurodevelopment.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100542"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12704061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15Epub Date: 2025-12-11DOI: 10.1016/j.xhgg.2025.100557
Loisa D Bonde, Tess Holling, Malik Alawi, Ahmed A El Beheiry, Zabih Mir Hassani, François Bachand, Ibrahim M Abdelrazek, Kerstin Kutsche
Ribosomes are ribonucleoproteins that are responsible for protein synthesis. They consist of ribosomal proteins and ribosomal RNAs (rRNAs). Pre-rRNAs are co-transcriptionally processed and chemically modified. The 2'-O-methylation of rRNAs is guided by box C/D small nucleolar ribonucleoprotein particles (snoRNPs), which are composed of a box C/D snoRNA and the core proteins NOP56, NOP58, SNU13, and the methyltransferase fibrillarin. Catalytically active box C/D snoRNPs function in nucleoli. We performed trio whole-exome sequencing in a proband with a severe neurodevelopmental disorder including global developmental delay, microcephaly, seizures, and ophthalmological and brain abnormalities and his healthy parents and identified the homozygous synonymous variant c.516G>A; p.Leu172= in NOP58. In fibroblasts of the proband, we demonstrated skipping of exon 7 in most NOP58 mRNAs, while ∼20% canonically spliced NOP58 transcripts were detected in the proband compared with control cells. NOP58 protein levels were reduced to ∼12% in proband cells that concomitantly reduced fibrillarin levels. Analysis of nucleoli in proband-derived fibroblasts revealed changes in the number of nucleolar condensates and in nucleolar morphology. We found reduced levels of three box C/D snoRNAs required for 2'-O-methylation and of one box C/D snoRNA important for 2'-O-methylation and pre-rRNA processing. Analysis of pre-rRNA maturation by RT-qPCR revealed increased 45S and 21S pre-rRNA levels, whereas the amplification signal for the 47S, 32S, and 26S pre-rRNAs was substantially decreased in proband compared with control cells. Together, our data unveil that the homozygous NOP58 variant c.516G>A represents a hypomorphic allele and underlies the neurodevelopmental phenotype in the proband, likely by impairing pre-rRNA maturation.
核糖体是负责蛋白质合成的核糖核蛋白。它们由核糖体蛋白和核糖体rna (RNAs)组成。pre - rrna被共转录加工和化学修饰。rnas的2'- o -甲基化由盒C/D小核仁核糖核蛋白颗粒(snoRNPs)引导,该颗粒由盒C/D snoRNA和核心蛋白NOP56、NOP58、SNU13和甲基转移酶纤维蛋白组成。催化活性盒C/D snoRNPs在核仁中起作用。我们对一名患有严重神经发育障碍(包括整体发育迟缓、小头畸形、癫痫、眼科和脑部异常)的先证者及其健康父母进行了三组全外显子组测序,并鉴定出纯合子同义变异c.516G> a;p.Leu172= in NOP58。在先证者的成纤维细胞中,我们证实了大多数NOP58 mrna的外显子7的跳跃,而与对照细胞相比,先证者中检测到约20%的正常剪接的NOP58转录物。先证者细胞中的NOP58蛋白水平降低至12%,同时降低了纤维蛋白水平。先证者衍生成纤维细胞核仁的分析显示核仁凝聚物的数量和核仁形态的变化。我们发现2'- o -甲基化所需的三个盒C/D snoRNA水平降低,2'- o -甲基化和前rrna加工重要的一个盒C/D snoRNA水平降低。通过RT-qPCR分析pre-rRNA成熟,发现先证体中45S和21S pre-rRNA水平升高,而47S、32S和26S pre-rRNA的扩增信号与对照细胞相比显著降低。总之,我们的数据揭示了纯合子NOP58变异体c.516G>A代表了一种次形等位基因,并可能通过损害rrna前成熟而成为先证体神经发育表型的基础。
{"title":"A homozygous synonymous NOP58 variant causes a neurodevelopmental disorder by impairing maturation of pre-ribosomal RNAs.","authors":"Loisa D Bonde, Tess Holling, Malik Alawi, Ahmed A El Beheiry, Zabih Mir Hassani, François Bachand, Ibrahim M Abdelrazek, Kerstin Kutsche","doi":"10.1016/j.xhgg.2025.100557","DOIUrl":"10.1016/j.xhgg.2025.100557","url":null,"abstract":"<p><p>Ribosomes are ribonucleoproteins that are responsible for protein synthesis. They consist of ribosomal proteins and ribosomal RNAs (rRNAs). Pre-rRNAs are co-transcriptionally processed and chemically modified. The 2'-O-methylation of rRNAs is guided by box C/D small nucleolar ribonucleoprotein particles (snoRNPs), which are composed of a box C/D snoRNA and the core proteins NOP56, NOP58, SNU13, and the methyltransferase fibrillarin. Catalytically active box C/D snoRNPs function in nucleoli. We performed trio whole-exome sequencing in a proband with a severe neurodevelopmental disorder including global developmental delay, microcephaly, seizures, and ophthalmological and brain abnormalities and his healthy parents and identified the homozygous synonymous variant c.516G>A; p.Leu172= in NOP58. In fibroblasts of the proband, we demonstrated skipping of exon 7 in most NOP58 mRNAs, while ∼20% canonically spliced NOP58 transcripts were detected in the proband compared with control cells. NOP58 protein levels were reduced to ∼12% in proband cells that concomitantly reduced fibrillarin levels. Analysis of nucleoli in proband-derived fibroblasts revealed changes in the number of nucleolar condensates and in nucleolar morphology. We found reduced levels of three box C/D snoRNAs required for 2'-O-methylation and of one box C/D snoRNA important for 2'-O-methylation and pre-rRNA processing. Analysis of pre-rRNA maturation by RT-qPCR revealed increased 45S and 21S pre-rRNA levels, whereas the amplification signal for the 47S, 32S, and 26S pre-rRNAs was substantially decreased in proband compared with control cells. Together, our data unveil that the homozygous NOP58 variant c.516G>A represents a hypomorphic allele and underlies the neurodevelopmental phenotype in the proband, likely by impairing pre-rRNA maturation.</p>","PeriodicalId":34530,"journal":{"name":"HGG Advances","volume":" ","pages":"100557"},"PeriodicalIF":3.6,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12800697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145744855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}